Chronic Obstructive Pulmonary Diseases and Proprioceptive Neuromuscular Facilitation

Study Overview
=================
Brief Summary
-----------------
To investigate the effects of resistant proprioceptive neuromuscular facilitation exercises on physical fitness, respiratory muscle strength, walking distance and quality of life in chronic obstructive pulmonary patients.

Detailed Description
-----------------
The study was carried out between January 2017 and January 2019, with patients followed up with the diagnosis of COPD in Çanakkale Mehmet Akif Ersoy State Hospital and Çanakkale Onsekiz Mart University Medical Faculty Hospital, Department of Chest Diseases. It was approved by Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Date: 30.12.2016, Decision No. 573) and was done in accordance with the Declaration of Helsinki. All participants were informed about the purpose of the study, the total duration of treatment and the applications to be made, and a consent form was signed. The study was conducted as a prospective and randomized controlled study, and inclusion and exclusion criteria were determined. Thirty-five patients diagnosed with COPD were referred to the study, four patients were excluded because they did not meet the inclusion criteria, and the study was conducted with a total of 31 participants. The 31 patients included in the study were randomized after their initial evaluation and divided into two groups as experimental and control groups. Patients meeting the inclusion criteria were divided into 2 groups. Randomized by ordering by date of application.

Official Title
-----------------
The Effect of Resistant Proprioceptive Neuromuscular Facilitation Exercises on Respiratory Muscle Strength in Chronic Obstructive Pulmonary Diseases

Conditions
-----------------
Chronic Obstructive Pulmonary Disease

Intervention / Treatment
-----------------
* Diagnostic Test: MIP/MEP


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: To be diagnosed with stage 1, stage 2 and stage 3 COPD according to GOLD (Global Initiative for Obstructive Lung Diseases) criteria Having FEV1/FVC <70% according to pulmonary function test Being clinically stable Being over 18 years old Volunteer to participate in the program Exclusion Criteria: Having a COPD exacerbation in the last 8 weeks To have participated in a regular exercise training program in the last 1 year Having a musculoskeletal disease and neuromuscular disease that may prevent exercise Inability to cooperate for pulmonary function test and respiratory muscle strength measurement Being on long-term oxygen therapy

Ages Eligible for Study
-----------------
Minimum Age: 38 Years
Maximum Age: 67 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Maximal Inspiratory Pressure<br>MIP Maximal Inspiratory Pressure | Diagnostic Test: MIP/MEP<br>* MIP/MEP<br>|
| Experimental: Maximal Expiratory Pressure<br>MEP Maximal Expiratory Pressure | Diagnostic Test: MIP/MEP<br>* MIP/MEP<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| HADS | Hospital Anxiety Depression Scale | 10 minutes | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| SGRQ | St George's Respiratory Questionnaire | 15 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
COPD